BioCryst Pharmaceuticals | BCRX - Рыночная капитализация





Рыночная капитализация Изменить Дата
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Chugai Pharma JPY 12.65T 1.81T 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novavax USD 1.09B 316M 2025-12
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06